Option chain shows key data for Roche Holding's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Roche Holding.

Roche Holding (OTC:RHHBY) Stock, Option Chain

Roche Holding

ROCHE HLDG LTD SPONS

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

RHHBY

VKTX


([content-module:CompanyOverview, NASDAQ:VKTX)
The GLP-1 industry is currently an oligopoly ruled by two pharmaceutical giants, Novo Nordisk A/S (NYSE:NVO), maker of semaglutide under the Ozempic and Wegovy name

Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?

Viersen,,Germany,-,May,9.,2020:,Close,Up,Of,Mobile

Analyst Color

Equities

News

Price Target

Reiteration

Markets

Analyst Ratings

Movers

Trading Ideas

General

TEVA

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug&#39;s potential in treating IBD.

Teva&#39;s Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data

Collapsing,Dna,Molecules,On,A,Blurred,Background.

Biotech

Health Care

SRPT

Sarepta&#39;s EMBARK study confirms Elevidys offers sustained Duchenne treatment benefits, including motor function improvement and minimal muscle pathology progression.

Sarepta Therapeutics&#39; Duchenne Gene Therapy Shows Sustained Benefits And Disease Stabilization At Two Years

ROCHE HOLDING LTD S/ADR by Roche Holding Ltd

Roche Holding AG

Small Cap

Opinion

Press Releases

Healthcare Executives Embrace Generative AI to Boost Patient Outcomes

Genentech's Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson's Disease

Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate

Roche's momentum in digital pathology continues with FDA clearance on its high-volume slide scanner

Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma

Dyno Therapeutics Announces Exercise of Option by Roche for Next-Generation AAV Vector for Neurological Gene Therapy

Genentech's Itovebi Demonstrated Statistically Significant and Clinically Meaningful Overall Survival Benefit in a Certain Type of HR-Positive Advanced Breast Cancer

FDA Approves Genentech's Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness

New England Journal of Medicine Publishes New Data for Genentech's Gazyva Which Shows Superiority Over Standard Therapy in People With Active Lupus Nephritis

FDA Approves Genentech's Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)

Comments

Roche Holding

Roche Holding (RHHBY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga